JBI evidence synthesis · 2026
Experiences of people with diabetes mellitus during the COVID-19 pandemic utilizing telehealth for diabetes management: a qualitative systematic review.
СтатьяСистематический обзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gerrie Alexander, Bellman Susan, Pollock Danielle
Аннотация
OBJECTIVE: The objective of this review was to explore the experiences of people with diabetes mellitus who utilized telehealth for diabetes management due to COVID-19 pandemic.
INTRODUCTION: COVID-19 intensified globally from January 2020, eliciting a multinational response to infection control for health preservation, including social distancing in public areas and health. The outcome had significant impact on the health care system, where persons with chronic diseases such as diabetes were required to transition a majority of their care to telehealth to align with social restrictions. To date, research has not addressed a synthesis or critical analysis in systematic reviews addressing the experiences of people with diabetes mellitus receiving care, and what effect this rapid shift to telehealth had compared with traditional in-person consultations.
ELIGIBILITY CRITERIA: This review included primary qualitative or mixed methods studies of any research design that examined the experiences of adult with diabetes transitioning from in-person consultations to telehealth during the COVID-19 pandemic. Exclusions included quantitative studies; secondary, tertiary, and gray literature; and literature pre-COVID-19.
METHODS: This review was conducted according to JBI guidance on qualitative systematic reviews. A search of CINAHL (EBSCOhost), Scopus, Embase, Emcare (Ovid), PubMed, and ProQuest Central was conducted. Studies from January 2020 onward in any language were assessed for eligibility. Two reviewers independently screened studies and assessed the methodological quality of the included studies using the JBI Qualitative Critical Appraisal Tool. The included studies were synthesized using JBI meta-aggregation, and the confidence in the findings was assessed with ConQual.
RESULTS: The reviewers screened 1491 titles and abstracts, and 9 studies were selected for inclusion. Three synthesized findings were identified: i) The provision of care and diabetes self-management capabilities utilizing telehealth was based on the awareness and acceptance of services, the perceived quality of communication, and the ability for patients to access safe and quality health assessments and care; ii) Telehealth was seen as logistically convenient, saving effort, money, and time through reduced travel for patients; and iii) Telehealth requires user-friendly infrastructure that considers accessibility, connectivity, compatibility, and digital health literacy.
CONCLUSIONS: The review validates the existing utilization of telehealth for diabetes care, further suggesting implementation of formalized telehealth as a hybrid model service for diabetes care delivery beyond the pandemic.
REVIEW REGISTRATION: PROSPERO CRD4202342466.
INTRODUCTION: COVID-19 intensified globally from January 2020, eliciting a multinational response to infection control for health preservation, including social distancing in public areas and health. The outcome had significant impact on the health care system, where persons with chronic diseases such as diabetes were required to transition a majority of their care to telehealth to align with social restrictions. To date, research has not addressed a synthesis or critical analysis in systematic reviews addressing the experiences of people with diabetes mellitus receiving care, and what effect this rapid shift to telehealth had compared with traditional in-person consultations.
ELIGIBILITY CRITERIA: This review included primary qualitative or mixed methods studies of any research design that examined the experiences of adult with diabetes transitioning from in-person consultations to telehealth during the COVID-19 pandemic. Exclusions included quantitative studies; secondary, tertiary, and gray literature; and literature pre-COVID-19.
METHODS: This review was conducted according to JBI guidance on qualitative systematic reviews. A search of CINAHL (EBSCOhost), Scopus, Embase, Emcare (Ovid), PubMed, and ProQuest Central was conducted. Studies from January 2020 onward in any language were assessed for eligibility. Two reviewers independently screened studies and assessed the methodological quality of the included studies using the JBI Qualitative Critical Appraisal Tool. The included studies were synthesized using JBI meta-aggregation, and the confidence in the findings was assessed with ConQual.
RESULTS: The reviewers screened 1491 titles and abstracts, and 9 studies were selected for inclusion. Three synthesized findings were identified: i) The provision of care and diabetes self-management capabilities utilizing telehealth was based on the awareness and acceptance of services, the perceived quality of communication, and the ability for patients to access safe and quality health assessments and care; ii) Telehealth was seen as logistically convenient, saving effort, money, and time through reduced travel for patients; and iii) Telehealth requires user-friendly infrastructure that considers accessibility, connectivity, compatibility, and digital health literacy.
CONCLUSIONS: The review validates the existing utilization of telehealth for diabetes care, further suggesting implementation of formalized telehealth as a hybrid model service for diabetes care delivery beyond the pandemic.
REVIEW REGISTRATION: PROSPERO CRD4202342466.